These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16821163)

  • 21. Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome.
    Ding C
    Curr Opin Investig Drugs; 2006 Nov; 7(11):1020-5. PubMed ID: 17117592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common questions in managing hyperlipidemia.
    Rosen IM; Sams RW
    Prim Care; 2006 Dec; 33(4):903-21. PubMed ID: 17169673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FPIN's clinical inquiries. Best alternatives to statins for treating hyperlipidemia.
    Bouknight P; Mackler L; Heffington M
    Am Fam Physician; 2007 Oct; 76(7):1027-9. PubMed ID: 17956075
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug therapy of hyperlipidemia--unanswered questions].
    Osmundsen K
    Tidsskr Nor Laegeforen; 1997 Apr; 117(9):1334. PubMed ID: 9182369
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia.
    Farnier M; Roth E; Gil-Extremera B; Mendez GF; Macdonell G; Hamlin C; Perevozskaya I; Davies MJ; Kush D; Mitchel YB;
    Am Heart J; 2007 Feb; 153(2):335.e1-8. PubMed ID: 17239698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hyperlipidemia].
    Haraldsen M
    Tidsskr Nor Laegeforen; 1996 Jan; 116(1):112. PubMed ID: 8553322
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.
    Kesäniemi A
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():29-30. PubMed ID: 18001318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical inquiries. Should we identify and treat hyperlipidemia in the advanced elderly?
    Shah K; Rogers J; Britigan D; Levy C
    J Fam Pract; 2006 Apr; 55(4):356-7. PubMed ID: 16608678
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug evaluation: MGCD-0103, a histone deacetylase inhibitor for the treatment of cancer.
    Kell J
    Curr Opin Investig Drugs; 2007 Jun; 8(6):485-92. PubMed ID: 17621879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of HuDan Granules on lipid metabolism and antioxidant activity of mice with hyperlipidemia].
    Zheng MW; Zheng L
    Zhong Yao Cai; 2008 Mar; 31(3):410-2. PubMed ID: 18619250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer.
    Tamm I
    Curr Opin Investig Drugs; 2008 Jun; 9(6):638-46. PubMed ID: 18516763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The biology and chemistry of hyperlipidemia.
    Jain KS; Kathiravan MK; Somani RS; Shishoo CJ
    Bioorg Med Chem; 2007 Jul; 15(14):4674-99. PubMed ID: 17521912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo profile of 5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide (dirlotapide), a novel potent MTP inhibitor for obesity.
    Li J; Bronk BS; Dirlam JP; Blize AE; Bertinato P; Jaynes BH; Hickman A; Miskell C; Pillai UA; Tibbitts JS; Haven ML; Kolosko NL; Barry CJ; Manion TB
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1996-9. PubMed ID: 17276061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Piperazine sultosylate in the treatment of hyperlipidemias].
    Balaguer Vintro I; Duarte Mantilla G
    Rev Clin Esp; 1980 Jul 15-31; 158(1-2):37-40. PubMed ID: 6999559
    [No Abstract]   [Full Text] [Related]  

  • 36. Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia.
    Longhurst H
    Curr Opin Investig Drugs; 2008 Mar; 9(3):310-23. PubMed ID: 18311668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug evaluation: LB-80380--a novel phosphonate nucleoside for the potential treatment of HBV infection.
    Papatheodoridis GV; Manolakopoulos S
    Curr Opin Mol Ther; 2006 Aug; 8(4):352-7. PubMed ID: 16955699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synthesis and antihyperlipidemic activities of benzylidenebenzofuran- 3 (2H) ones].
    Hauad L; Fulcrand P; Chevallet P; Darmanaden R; Serrano JJ; Castel J
    Ann Pharm Fr; 1987; 45(6):459-65. PubMed ID: 3504121
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.
    Geerts H
    IDrugs; 2007 Feb; 10(2):121-33. PubMed ID: 17285465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.